Markets
Tech
Media
Success
Video
Markets
Premarkets
Dow
After-Hours
Market Movers
Fear & Greed
World Markets
Investing
Markets Now
Before the Bell
Leading Indicator
Global Energy Challenge
Economy
Energy
Tech
Innovate
Gadget
Mission: Ahead
Upstarts
Business Evolved
Work Transformed
Innovative Cities
Unhackable
Media
Reliable Sources
Success
Boss Files
Fresh Money
Cars
Homes
Biz + Leisure
Center Piece
Perspectives
Video
International
Switzerland
India
Davos
Passion to Portfolio
On: Germany
More
Newsletters
About Us
Accessibility and CC
U.S.
World
Politics
Business
Opinion
Health
Entertainment
Tech
Style
Travel
Sports
Video
Shop
VR
More...
Follow CNN Business
Do Not Sell
Y-mAbs Therapeutics Inc
(NASDAQ:YMAB)
5.78
Delayed Data
As of Sep 27
+0.42
/
+7.85%
Today’s Change
2.70
Today
|||
52-Week Range
15.89
+18.44%
Year-to-Date
Quote
Profile
News
Charts
Forecasts
Financials
Shareholders
Competitors
1 day
3 days
5 days
1 month
3 month
6 month
YTD
1 year
3 year
5 year
Y-mAbs Therapeutics Inc
Use the checkboxes below to add to the chart.
Major Benchmarks
Today’s
change
1 year
change
1 year
trend
INX
S&P 500 INDEX
+0.02%
+17.20%
INDU
Dow Jones Industrial Average
-0.20%
+15.15%
Peers & Competitors
Market cap
P/E ratio
Today’s
change
1 year
change
1 year
trend
YMAB
Y-mAbs Therapeutics Inc
$227.7M
NM
+7.85%
-59.21%
ACIU
AC Immune SA
--
NM
0.00%
+19.05%
OCUL
Ocular Therapeutix Inc
--
NM
-1.24%
-26.33%
SCPH
scPharmaceuticals Inc
--
NM
-1.12%
+38.16%
Add